Hopes Up for Sanofi Obesity Drug, 2-Year Data Eyed
475056
Expectations rose for Sanofi-Aventis's big new drug hope Acomplia on Friday as the French firm revealed it would present two-year, rather than one-year, data on the anti-obesity medicine next week.
426972
A new anti-obesity drug that works in  the same way as Sanofi-Aventis's Acomplia has advanced in  clinical trials, triggering a $25 million payment to Belgian  drugs, chemicals and plastics maker Solvay.
448598
Drugs to raise so-called good cholesterol may still have a future despite the widely publicized failure last year of an experimental cholesterol treatment from Pfizer, researchers said.
266489
A new drug from Sanofi-Aventis reduced  significantly episodes of atrial fibrillaton or irregular heart  beat in two clinical studies released on Sunday.
667206
30/08/2004 A new miracle drug for obesity could prove central to the fortunes of manufacturer Sanofi-Aventis, a newly-merged firm, if the French company is successful in bringing it to the market.
404075
New evidence is raising questions about the tests used to prescribe the breast cancer drug Herceptin, which was initially seen as a model for tailored medicine.
768183
An experimental drug from Sanofi-Aventis, viewed as pivotal to the newly merged company's future, showed good results in the largest clinical study of the product to date.
458557
An experimental drug from  Sanofi-Aventis, viewed as pivotal to the newly merged company's  future, showed good results in the largest clinical study of  the product to date.
672501
NEW YORK  - A drug approved for the treatment of arthritis may have a role in reducing the risk of diabetes and heart trouble developing in young obese individuals, Harvard researchers report.
753810
Amid growing concerns, the maker of the widely sold arthritis drug announced Monday that it will soon begin a major clinical trial to determine whether the drug is safe for long-term use.
479416
Patients who took a Sanofi-Aventis SA obesity drug in clinical trials were more likely to report suicidal thoughts or actions than others who got a placebo, U.S. drug reviewers said in an analysis released on Monday.
124030
Almost one-fifth of the Food and Drug Administration scientists surveyed two years ago as part of an official review said they had been pressured to recommend approval of a new drug despite
725261
There's encouraging news about an enzyme replacement drug.
403138
NEW ORLEANS - An experimental pill that offers the promise of helping people lose weight and quit smoking has raised more expectations.
325918
At least that&#39;s what NABI Biopharmaceuticals (Nasdaq: NABI) suggests based on the results of a small phase 2 trial with the drug NicVAX that was released yesterday.
683607
AtheroGenics announces the path forward for its lead drug.
494299
Sanofi-Aventis expects to get a decision from U.S. regulators by April 26 on whether it may sell anti-obesity pill and potential blockbuster Acomplia in the world's largest drug market, following a six-month review.